Ocugen, Inc.
OCGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 27.6% | -7.3% | 93.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,015.2% | -937.2% | -917.8% | -1,733.2% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,144.5% | -1,073.5% | -1,036.5% | -1,816.8% |
| EPS Diluted | -0.066 | -0.051 | -0.053 | -0.048 |
| % Growth | -30.7% | 4% | -10.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |